BXSDiagnosticsbusinesswire

Case Study: CyPath® Lung Identifies Lung Cancer in Patient with Difficult-to-Diagnose Ground-Glass Pulmonary Nodules

Sentiment:Positive (80)

Summary

(NYSE:BXS) SAN ANTONIO--(BUSINESS WIRE)-- #BIAF--CyPath® Lung identifies incidentally found ground-glass lung nodules, leading to early diagnosis and timely treatment.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on September 9, 2025 by businesswire